ICON   Report issue

Founded: Dublin Ireland (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2002
NCT00057616
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GloboMax | GloboMax (ICON plc) | Healthcare Discoveries d/b/a ICON Development Solutions | ICON Bioscience Inc | ICON Cancer Care, Queensland, Australia | Icon Cancer Care South Brisbane | ICON Clinical Research | ICON Clinical Research Limited | ICON Developmental Solutions | ICON Development Solutions | ICON Development Solutions, LLC | ICON Development Solutions Manchester, Manchester Science Park, Manchester, UK | ICON Development Solutions Manchester, UK | ICON Development Solutions, Manchester, UK | ICON Development Solutions UK | ICON Early Phase Service | ICON Early Phase Services | ICON Early Phase Services/CRU | ICON Early Phase Services, LLC | ICON Early Phase Services (Parts 1 & 2) | ICON GPHS | Icon, Inc. | ICON Manchester CPU | ICON plc | ICON plc, 8307 Gault Lane, San Antonio TX 78209